THERACRYF PLC
Developing sulforaphane-based therapeutics for oncology and behavioural brain disorders.
TCF | IL
Overview
Corporate Details
- ISIN(s):
- GB00BMVN2C70 (+2 more)
- LEI:
- 213800NO3E6TSTQO8K20
- Country:
- United Kingdom
- Address:
- SUITE 24G13 - BLOCK 24, SK10 4TG NETHER ALDERLEY
- Website:
- https://theracryf.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
TheraCryf PLC is a clinical-stage therapeutics company developing a new generation of innovative medicines focused on oncology and behavioural brain disorders. The company's pipeline is based on sulforaphane-based therapeutics. TheraCryf's strategy is to advance its drug candidates through clinical trials to generate compelling data, with the objective of partnering its programs with mid-size to large pharmaceutical companies for late-stage development and commercialization.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-10-10 08:00 |
Regulatory News Service
World Mental Health Day & Q4 Conference Schedule
|
English | 16.5 KB | ||
| 2025-09-26 16:45 |
Major Shareholding Notification
Holding(s) in Company
|
English | 23.5 KB | ||
| 2025-09-08 12:38 |
Major Shareholding Notification
Holding(s) in Company
|
English | 23.9 KB | ||
| 2025-09-04 08:00 |
Regulatory News Service
Ox-1 Patent Grant & Development Programme Update
|
English | 17.3 KB | ||
| 2025-08-04 16:27 |
Major Shareholding Notification
Holding(s) in Company
|
English | 23.3 KB | ||
| 2025-07-17 08:00 |
Regulatory News Service
Manufacturing Scale Up of Lead Ox-1 Programme
|
English | 14.1 KB | ||
| 2025-07-09 16:07 |
Post-Annual General Meeting Information
Result of AGM
|
English | 12.3 KB | ||
| 2025-06-16 17:10 |
Report Publication Announcement
Notice of AGM
|
English | 13.0 KB | ||
| 2025-06-10 13:32 |
Investor Presentation
Ox-1 Investor Presentation
|
English | 11.6 KB | ||
| 2025-06-03 08:00 |
Earnings Release
Final results for year to 31 March 2025
|
English | 235.9 KB | ||
| 2025-05-23 08:14 |
Report Publication Announcement
Notice of Results and Ox-1 presentation
|
English | 12.5 KB | ||
| 2025-05-22 13:43 |
Major Shareholding Notification
Holding(s) in Company
|
English | 52.1 KB | ||
| 2025-05-16 14:00 |
Major Shareholding Notification
Holding(s) in Company
|
English | 23.2 KB | ||
| 2025-03-26 08:00 |
Investor Presentation
Investor webinar
|
English | 16.2 KB | ||
| 2025-03-19 13:10 |
Major Shareholding Notification
Holding(s) in Company
|
English | 23.3 KB |
Automate Your Workflow. Get a real-time feed of all THERACRYF PLC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for THERACRYF PLC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
